Clinical Trial Update: Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment

View source ↗

Summary

This completed clinical trial update evaluates whether the severity of bleeding predicts quality of life in women with heavy menstrual bleeding treated with dyd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menorrhagia
• Metrorrhagia

Drugs mentioned

• Dydrogesterone (dydrogesterone)

Snippet

Sponsor: Abbott | Conditions: Menorrhagia, Metrorrhagia | Status: COMPLETED